Serial Number | 97257564 |
Word Mark | CIGNPOST |
Filing Date | Tuesday, February 8, 2022 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Tuesday, December 5, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of the literal element "Cignpost" in blue; the "o" is represented by the design of a compass in black and pink. |
Indication of Colors claimed | The color(s) blue, black, and pink is/are claimed as a feature of the mark. |
Goods and Services | Medical diagnostic testing services; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical information; Medical consultation; Medical counselling; Medical services; Medical clinics; Medical screening; Medical evaluation services for patients with viruses; Medical advisory services relating to the treatment of patients; Providing medical information services; Medical analysis services relating to the treatment of persons; Medical information services; Medical care services; Medical treatment services for the treatment of COVID-19; Medical clinic services; Medical equipment rental; Medical assistance services; Medical health assessment services; Medical examination services of individuals; Rental of medical equipment; Rental of medical apparatus; Leasing of medical equipment; Provision of medical facilities; Provision of medical services; Conducting of medical examinations services; Mobile medical clinic services; Medical and managed healthcare services; Genetic testing for medical purposes; DNA screening for medical purposes; Medical and health services in the nature of DNA, genetics and genetic testing; Medical testing services relating to the diagnosis and treatment of disease; Performing diagnosis of diseases; Medical analysis services for the diagnosis of COVID 19; Medical analysis for the diagnosis and treatment of persons; RNA and DNA analysis for COVID-19 diagnosis and screening services; COVID-19 screening services; on-site COVID-19 screening and testing services; temperature checking services as part of COVID-19 screening services; information, advisory and consultancy services regarding the aforementioned services |
Goods and Services | Electromedical diagnostic instruments for cardiovascular diagnostics; Medical diagnostic instruments for the analysis of blood and saliva; Medical diagnostic saliva collection pads; Fingerstalls in the nature of support bandages for diagnostic purposes; Medical diagnostic saliva collection vials; Ultrasonic medical diagnostic apparatus; Tools for medical diagnostics, namely, swabs, needles and other blood taking tools; Diagnostic instruments for medical use, namely, diagnosing COVID-19 or underlying health issues; Diagnostic, examination, and monitoring equipment, namely, body composition monitors, heart rate monitors and blood pressure monitors; Diagnostic apparatus for medical purposes for testing for COVID-19 and underlying health conditions; diagnostic measuring apparatus for medical use, namely, analyzing blood and measuring composition of the body; Medical diagnostic apparatus for medical purposes, namely, blood testing apparatus and blood pressure measuring apparatus; Testing probes for medical diagnostic purposes; Testing instruments for medical diagnostic purposes, namely, blood and saliva testing; Diagnostic imaging apparatus for medical use in the nature of an x-ray apparatus; Medical diagnostic apparatus for testing for viruses; Medical diagnostic testing apparatus for use in immunoassay procedures; Apparatus for carrying-out diagnostic tests for medical purposes, namely, syringes for medical purposes; Medical spittoons; Medical gowns; Medical masks for use by medical personnel; Medical instruments for use in cardiovascular screening and blood analysis procedures; Medical devices for detecting Covid-19 and underlying health issues; Medical examination gloves; Medical analytical apparatus for medical purposes, namely, blood testing apparatus; Medical analysis instruments, namely, syringes for medical purposes; Medical testing instruments for use in analyzing blood and identifying issues; Latex medical gloves; Gloves for medical examinations; Respirators for artificial respiration for medical purposes; Medical bags designed to hold medical instruments in the nature of blood testing apparatus; Containers for medical waste; Nebulizers for medical use; Gloves for medical use; X-ray CT scanners for medical diagnosis; Inhalers for medical use; Hematology analyzers for medical diagnostic use; Medical apparatus and devices, namely, syringes for medical purposes; Medical apparatus and instruments, namely, blood testing apparatus; Respiratory masks for medical purposes; Examination gloves for medical use; Detecting instruments for medical use, namely, biosensors for detecting infectious diseases; Respiration monitors for medical use; Temperature meters for medical use; Medical apparatus for assisting breathing; Portable nebulisers for medical purposes; Scanning instruments for medical use, namely, myocardial ischemia scanning devices; Scanning machines for medical use, namely, medical x-ray apparatus; Scanning apparatus for medical use, namely, x-ray apparatus; Digital thermometers for medical purposes; Hematology automatic analyzers for medical diagnosis; Pulse measuring devices for medical use; Specimen samplers for medical use, namely, medical specimen bags for holding body fluid samples for testing; Analytical instruments for medical use, namely, analysis of blood samples; Test equipment for medical use, namely, blood and saliva testing; Electronic temperature monitors for medical use; Protective clothing for medical purposes, namely, personal protective equipment; Test probes for medical use; Testing probes for medical purposes; diagnostic testing apparatus for medical purposes for viruses; Medical instruments for infectious disease testing; Lung function test apparatus for medical use; Apparatus for blood testing for medical purposes; Diagnostic testing instruments for use in immunoassay procedure; Apparatus for DNA and RNA testing for medical purposes; Medical probes; Probes for medical purposes |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 14, 2022 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 14, 2022 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Cignpost Investments Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Farnborough, Hampshire GU140LX GB |
Event Date | Event Description |
Tuesday, December 5, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Tuesday, December 5, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Tuesday, December 5, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Tuesday, June 20, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Tuesday, June 20, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Saturday, April 15, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Saturday, April 15, 2023 | FINAL REFUSAL E-MAILED |
Saturday, April 15, 2023 | FINAL REFUSAL WRITTEN |
Saturday, March 4, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Saturday, March 4, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, March 3, 2023 | ASSIGNED TO LIE |
Tuesday, December 20, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Saturday, October 1, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Saturday, October 1, 2022 | NON-FINAL ACTION E-MAILED |
Saturday, October 1, 2022 | NON-FINAL ACTION WRITTEN |
Tuesday, September 27, 2022 | ASSIGNED TO EXAMINER |
Tuesday, February 15, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Monday, February 14, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, February 11, 2022 | NEW APPLICATION ENTERED |